US Patent Issued to Nanjing Immunophage Biotech on July 14 for "Compounds and their uses as CD38 inhibitors" (Chinese Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,832, issued on July 14, was assigned to Nanjing Immunophage Biotech Co. Ltd. (Nanjing, China).

"Compounds and their uses as CD38 inhibitors" was invented by Jianbei Xi (Nanjing, China), Guohuang Fan (Nanjing, China), Jianfei Wang (Nanjing, China) and Kin Chiu Fong (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds of Formula I which can be used as CD38 inhibitors; methods for the production of the compounds of the invention; pharmaceutical compositions comprising the compounds of the invention; as well as uses and methods for treating a disease mediated by CD38 by administering the compounds of th...